- Target
- Cytokeratin 16
- Reactivity
- Human,
- Application
- IHC,WB,IF,ELISA
- MW(Calculated)
- 51kD
- MW(Observed)
- 55kD
- Host Species
- Mouse
- Isotype
- IgG2b,Kappa
- Conjugate/Modification
- Unmodified
- Modification site
- --
- Recommended Dilution Ratio
- IHC 1:200-1000;WB 1:500-2000;IF 1:100-500;ELISA 1:1000-5000
- Form
- PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
- Source
- --
- Purification
- Protein G
- Purity
- --
- storageCondition
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Concentration
- --
- Clonality
- Monoclonal
- Clone No.
- ABT059
- Immunogen
- Synthesized peptide derived from human CK16 AA range: 400-473
- Sequence
- --
- Specificity
- The antibody can specifically recognize human CK16 protein, and shows no cross reaction with CK1, 5, 6, 7, 8, 10, 13, 14, 15, 19, 20.
- Gene Name
- KRT16 KRT16A
- Protein Name
- Cytokeratin-16
- Other Name
- CK 16;CK-16;CK16;Cytokeratin 16;CytokeRatin-16;CytokeRatin16;FNEPPK;Focal non epidermolytic palmoplantar keRatoderma;K 16;K16;K1C16_HUMAN;K1CP;KeRatin 1 type I;KeRatin 16;KeRatin;KeRatin type I cytoskeletal 16;KeRatin-16;KeRatin16;KRT 16;Krt16;KRT16A;NEPPK;PC1;type I cytoskeletal 16
- Organism-1
- Human
- Gene ID-1
- 3868
- SwissProt-1
- P08779
- Organism-2
- --
- Gene ID-2
- --
- SwissProt-2
- --
- Organism-3
- --
- Gene ID-3
- --
- SwissProt-3
- --
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Cytoplasmic, Membranous